Insights On Outsourced Drug Development

  1. Early Development Considerations For Late-Stage NCE Success – Part One 12/8/2023

    Navigating NCE development can be daunting. Learn about the importance of assessing and mitigating risk at every stage of development and ensure that your NCE has the maximum potential for success.

  2. Evaluating Compound Toxicity Effects On Healthy Intestinal Organoids 3/24/2025

    3D organoids enhance drug toxicity prediction and are crucial for anti-cancer drug development. Examine a method using 3D mouse intestinal organoids that aims to provide vital data on intestinal toxicity.

  3. Integrating Phase-Appropriate Quality Standards 12/9/2024

    Incorporating phase-specific quality standards ensures GMP compliance throughout biopharmaceutical development. Collaborating with an experienced CDMO addresses late-stage quality needs and efficiently manages accelerated product development timelines.

  4. Preclinical Evaluation Of Vaccines And Antivirals In RSV Challenge Rodent Models 6/10/2025

    Here, we present multiple case studies utilizing clinically relevant mouse and rat models to evaluate key characteristics of potential RSV therapeutics.

  5. Simplify CAR-T Cell Manufacturing With LNP-Mediated Delivery 6/3/2025

    Streamline CAR-T cell manufacturing with lipid nanoparticles delivering base editors to create fratricide-resistant, CD45-edited CAR45 T cells, which enables scalable, precise, and potent therapies for blood cancers.

  6. Why DSC Testing Is A Critical Step In Developing Biosimilar Drugs 10/3/2024

    Explore the importance of testing in the regulatory process and how tools like Differential Scanning Calorimetry (DSC) are helping to bring more biosimilars to patients in need.

  7. Expanding Translational Research Concepts With Genedata Profiler 11/26/2024

    The biopharma industry leverages Genedata Profiler to integrate, curate, and analyze diverse R&D data, enabling collaborative, compliant, and AI-driven translational research to optimize drug development.

  8. Microglia: Where We Came From And Where We Are Now 10/8/2024

    Gain expert insights into the evolution of microglia research and the future of this field, including the innovative tools being developed to investigate the role of microglia in health and disease.

  9. Recommendations For Successful IND Approval Of RNA-LNP Drugs 8/22/2023

    The existing regulatory system is ambiguous for RNA therapeutics. Leverage this Investigational New Drug (IND) guide to help accelerate and strengthen the process IND filing of novel nanomedicines.

  10. The Key To Accelerating RNA-LNP Drug Development 12/27/2023

    Learn about the drug development hurdles that must be overcome to deliver on the promise of mRNA.